Pharmacy
Medicaid will see increased costs through beneficiaries’ direct payment of the drug, plus potentially higher Medicare premium payments.
The analysis will target aducanumab, recently approved by the FDA, as well as any future monoclonal antibodies that treat Alzheimer’s.
Vaccine Adverse Event Reporting data shows 95 hospitalizations and one reported death, out of 12.5 million doses administered.
FTC and DOJ officials say they will soon update their merger guidelines.
Pharmaceutical companies raised compensation for their top executives while steadily increasing drug prices, the committee found.
The strategic partnership is on track to open at least 600 primary care practices in more than 30 U.S. markets over the next four years.
Hospitals realized a 30% cut in reimbursement after an appeals court ruling upheld the Trump Administration decision.
This week's top stories include Scripps being hit with four class-action lawsuits, AWS creating a new accelerator, and five Blue Cross Blue Shield plans launching a for-profit company focused on lowering drug prices.
The program will first be made eligible to patients taking the biologic called Remicade, which treats inflammatory conditions.
The goal of the new organization is to improve medication affordability, clinical outcomes and medication experiences.